CN114159353A - 修复鼻粘膜的蜂巢润鼻膏及其制备方法 - Google Patents
修复鼻粘膜的蜂巢润鼻膏及其制备方法 Download PDFInfo
- Publication number
- CN114159353A CN114159353A CN202210015718.2A CN202210015718A CN114159353A CN 114159353 A CN114159353 A CN 114159353A CN 202210015718 A CN202210015718 A CN 202210015718A CN 114159353 A CN114159353 A CN 114159353A
- Authority
- CN
- China
- Prior art keywords
- parts
- beeswax
- propolis
- nasal mucosa
- nasal
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 210000002850 nasal mucosa Anatomy 0.000 title claims abstract description 25
- 238000002360 preparation method Methods 0.000 title claims abstract description 10
- 210000001331 nose Anatomy 0.000 title claims description 8
- 239000006071 cream Substances 0.000 title claims description 5
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims abstract description 44
- 235000013871 bee wax Nutrition 0.000 claims abstract description 36
- 241000241413 Propolis Species 0.000 claims abstract description 33
- 239000012166 beeswax Substances 0.000 claims abstract description 33
- 229940069949 propolis Drugs 0.000 claims abstract description 33
- 239000010495 camellia oil Substances 0.000 claims abstract description 24
- 229930003427 Vitamin E Natural products 0.000 claims abstract description 22
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims abstract description 22
- 235000012907 honey Nutrition 0.000 claims abstract description 22
- 235000019165 vitamin E Nutrition 0.000 claims abstract description 22
- 229940046009 vitamin E Drugs 0.000 claims abstract description 22
- 239000011709 vitamin E Substances 0.000 claims abstract description 22
- 239000001525 mentha piperita l. herb oil Substances 0.000 claims abstract description 21
- 235000019477 peppermint oil Nutrition 0.000 claims abstract description 21
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 11
- 238000003756 stirring Methods 0.000 claims description 6
- 238000001816 cooling Methods 0.000 claims description 4
- 238000004519 manufacturing process Methods 0.000 claims description 4
- 239000000203 mixture Substances 0.000 claims description 4
- 238000001914 filtration Methods 0.000 claims description 3
- 239000012535 impurity Substances 0.000 claims description 3
- 238000007493 shaping process Methods 0.000 claims description 3
- 239000000243 solution Substances 0.000 claims description 3
- 239000007766 cera flava Substances 0.000 claims description 2
- 229940100657 nasal ointment Drugs 0.000 claims 6
- 238000000034 method Methods 0.000 claims 2
- 206010039083 rhinitis Diseases 0.000 abstract description 16
- 230000000694 effects Effects 0.000 abstract description 12
- 230000000844 anti-bacterial effect Effects 0.000 abstract description 9
- 230000006870 function Effects 0.000 abstract description 4
- 230000003020 moisturizing effect Effects 0.000 abstract description 4
- 239000000126 substance Substances 0.000 abstract description 4
- 239000003205 fragrance Substances 0.000 abstract description 3
- 239000005445 natural material Substances 0.000 abstract description 2
- 231100000331 toxic Toxicity 0.000 abstract description 2
- 230000002588 toxic effect Effects 0.000 abstract description 2
- 241000264877 Hippospongia communis Species 0.000 description 16
- 206010061218 Inflammation Diseases 0.000 description 4
- 230000003110 anti-inflammatory effect Effects 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- 230000004054 inflammatory process Effects 0.000 description 4
- 239000002994 raw material Substances 0.000 description 4
- 230000036039 immunity Effects 0.000 description 3
- 210000003928 nasal cavity Anatomy 0.000 description 3
- KWGRBVOPPLSCSI-WPRPVWTQSA-N (-)-ephedrine Chemical compound CN[C@@H](C)[C@H](O)C1=CC=CC=C1 KWGRBVOPPLSCSI-WPRPVWTQSA-N 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- VOVIALXJUBGFJZ-KWVAZRHASA-N Budesonide Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@@H]2[C@@H]1[C@@H]1C[C@H]3OC(CCC)O[C@@]3(C(=O)CO)[C@@]1(C)C[C@@H]2O VOVIALXJUBGFJZ-KWVAZRHASA-N 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- 229960004436 budesonide Drugs 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 239000005556 hormone Substances 0.000 description 2
- 229940088597 hormone Drugs 0.000 description 2
- 230000002757 inflammatory effect Effects 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 239000007922 nasal spray Substances 0.000 description 2
- 229940097496 nasal spray Drugs 0.000 description 2
- 230000000474 nursing effect Effects 0.000 description 2
- CNNRPFQICPFDPO-UHFFFAOYSA-N octacosan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCCCO CNNRPFQICPFDPO-UHFFFAOYSA-N 0.000 description 2
- 239000002674 ointment Substances 0.000 description 2
- 210000000952 spleen Anatomy 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- REZQBEBOWJAQKS-UHFFFAOYSA-N triacontan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCO REZQBEBOWJAQKS-UHFFFAOYSA-N 0.000 description 2
- IXVMHGVQKLDRKH-YEJCTVDLSA-N (22s,23s)-epibrassinolide Chemical compound C1OC(=O)[C@H]2C[C@H](O)[C@H](O)C[C@]2(C)[C@H]2CC[C@]3(C)[C@@H]([C@H](C)[C@H](O)[C@@H](O)[C@H](C)C(C)C)CC[C@H]3[C@@H]21 IXVMHGVQKLDRKH-YEJCTVDLSA-N 0.000 description 1
- 229960002666 1-octacosanol Drugs 0.000 description 1
- 208000035143 Bacterial infection Diseases 0.000 description 1
- IXVMHGVQKLDRKH-VRESXRICSA-N Brassinolide Natural products O=C1OC[C@@H]2[C@@H]3[C@@](C)([C@H]([C@@H]([C@@H](O)[C@H](O)[C@H](C(C)C)C)C)CC3)CC[C@@H]2[C@]2(C)[C@@H]1C[C@H](O)[C@H](O)C2 IXVMHGVQKLDRKH-VRESXRICSA-N 0.000 description 1
- 206010048768 Dermatosis Diseases 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 108010003272 Hyaluronate lyase Proteins 0.000 description 1
- 102000001974 Hyaluronidases Human genes 0.000 description 1
- 241000257303 Hymenoptera Species 0.000 description 1
- 206010028748 Nasal obstruction Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 1
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 description 1
- 206010051496 Rhinalgia Diseases 0.000 description 1
- 206010039101 Rhinorrhoea Diseases 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 241000191963 Staphylococcus epidermidis Species 0.000 description 1
- 208000007107 Stomach Ulcer Diseases 0.000 description 1
- 241000194017 Streptococcus Species 0.000 description 1
- 241000193998 Streptococcus pneumoniae Species 0.000 description 1
- GUGOEEXESWIERI-UHFFFAOYSA-N Terfenadine Chemical compound C1=CC(C(C)(C)C)=CC=C1C(O)CCCN1CCC(C(O)(C=2C=CC=CC=2)C=2C=CC=CC=2)CC1 GUGOEEXESWIERI-UHFFFAOYSA-N 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 230000001387 anti-histamine Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 230000002155 anti-virotic effect Effects 0.000 description 1
- 239000000739 antihistaminic agent Substances 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 208000022362 bacterial infectious disease Diseases 0.000 description 1
- 230000003385 bacteriostatic effect Effects 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 150000003943 catecholamines Chemical class 0.000 description 1
- KWGRBVOPPLSCSI-UHFFFAOYSA-N d-ephedrine Natural products CNC(C)C(O)C1=CC=CC=C1 KWGRBVOPPLSCSI-UHFFFAOYSA-N 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 230000003467 diminishing effect Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- HHEAADYXPMHMCT-UHFFFAOYSA-N dpph Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1[N]N(C=1C=CC=CC=1)C1=CC=CC=C1 HHEAADYXPMHMCT-UHFFFAOYSA-N 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 229960002179 ephedrine Drugs 0.000 description 1
- 238000011841 epidemiological investigation Methods 0.000 description 1
- 208000001780 epistaxis Diseases 0.000 description 1
- 201000005917 gastric ulcer Diseases 0.000 description 1
- 208000007565 gingivitis Diseases 0.000 description 1
- 239000003862 glucocorticoid Substances 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 230000002949 hemolytic effect Effects 0.000 description 1
- 208000014617 hemorrhoid Diseases 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 229960002773 hyaluronidase Drugs 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 239000002085 irritant Substances 0.000 description 1
- 231100000021 irritant Toxicity 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 208000011309 nasal bleeding Diseases 0.000 description 1
- 208000010753 nasal discharge Diseases 0.000 description 1
- 201000009240 nasopharyngitis Diseases 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 235000005875 quercetin Nutrition 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 206010041232 sneezing Diseases 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 229940031000 streptococcus pneumoniae Drugs 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 229940126680 traditional chinese medicines Drugs 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
- A61K8/922—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/678—Tocopherol, i.e. vitamin E
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
- A61K8/927—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of insects, e.g. shellac
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/98—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin
- A61K8/987—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin of species other than mammals or birds
- A61K8/988—Honey; Royal jelly, Propolis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/005—Antimicrobial preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Birds (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Zoology (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Dermatology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Otolaryngology (AREA)
- Insects & Arthropods (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
本发明公开了一种修复鼻粘膜的蜂巢润鼻膏及其制作方法，主要以山茶油、蜂蜡、薄荷油、蜂蜜、蜂胶、维生素E等为原料，经过制备蜂蜡、蜂胶溶液配制、混合、低温静置定型等步骤制作而成。本发明利用老蜂巢制备的蜂蜡中含有的蜂巢素以及蜂胶、蜂蜜具有抗菌功能平衡鼻内菌群；利用天然蜂蜡及山茶油、薄荷油、维生素E的滋润保湿功能、将抗菌物质与鼻粘膜接触，以直达患部。而且组分均为天然物质，无毒副作用，无药味，且具备淡薄的香气，可长期使用，对鼻炎、感冒有很好的预防以及缓解效果。
Description
技术领域
本发明涉及一种润鼻膏，特别涉及一种修复鼻粘膜的蜂巢润鼻膏及其制备方法。
背景技术
鼻炎是由于病毒、病菌感染，或刺激物的作用下受损而导致的。鼻炎典型的病征通常表现为鼻塞、流涕、打喷嚏、鼻炎类型头痛、头昏等。鼻炎不单只是影响鼻子，同时还会影响咽喉和眼睛，这将会严重影响人的睡眠质量、听力以及学习能力等。受大气污染的影响，我国鼻炎患者不断增多，流行病学调查显示，目前我国鼻炎发病率已高达37％，并且每年以3％的速度递增，青少年儿童鼻炎患者占鼻炎群体的2/3，同时鼻炎每年以3％(2000万-3000万)的人数在逐渐增加。
目前，临床对鼻炎主要采用布地奈德鼻喷剂等药物来抑制炎性因子释放，减轻对鼻黏膜造成的炎症性损伤，从而有效改善患者症状。但长期临床实践发现，单用布地奈德鼻喷剂等药物治疗鼻炎存在一定局限性，主要体现在用药后对患者机体炎症反应的控制效果不佳，且短期内有着较高的复发率。现有鼻腔护理的产品多以糖皮质激素、抗组胺制剂、麻黄碱滴剂为主要成分，或使用不同类型的激素进行制备，或采用中药进行制备；激素可以治疗急性鼻炎但不能长期使用，中药可以排毒，但有较浓重的药味，不能被大众所接受；且现有的鼻腔护理产品保存时间短。
发明内容
本发明要解决的技术问题是提供一种修复鼻粘膜的蜂巢润鼻膏，以解决上述背景技术中的技术问题。
本发明的技术方案为：
一种修复鼻粘膜的蜂巢润鼻膏，包括以下组分：山茶油、蜂蜡、薄荷油、蜂蜜、蜂胶、维生素E。
进一步的，所述组分的重量份比例为：山茶油45～55份、蜂蜡12～20份、薄荷油3～6份、蜂蜜12～20份、蜂胶8～14份、维生素E 0.1～0.3份。
进一步的，所述组分的重量份比例为：山茶油45份、蜂蜡12份、薄荷油3份、蜂蜜12份、蜂胶8份、维生素E 0.1份。
进一步的，所述组分的重量份比例为：山茶油55份、蜂蜡20份、薄荷油6份、蜂蜜20份、蜂胶14份、维生素E 0.3份。
进一步的，组分的重量份比例为：山茶油50份、蜂蜡16份、薄荷油4份、蜂蜜16份、蜂胶11份、维生素E 0.2份。
本发明还提供了一种上述修复鼻粘膜的蜂巢润鼻膏的制造方法，技术方案如下：
一种修复鼻粘膜的蜂巢润鼻膏的制作方法，包括以下步骤：
(1)制备蜂蜡：采集天然老蜂巢，加水熬制后过滤去除杂质，制备纯净的蜂蜡；
(2)蜂胶溶液配制：将蜂胶放入适量酒精内，反复搅动直至溶解得蜂胶溶液；
(3)将蜂胶溶液、山茶油、薄荷油、蜂蜜、维生素E按比例加入蜂蜡，并搅拌均匀；
(4)低温静置定型：将配制好的混合物自然降温成型。
进一步的，步骤1中，蜂蜡与水的重量比例为1:2-2.5，大火烧至沸腾后，文火熬制30-40min。
进一步的，步骤2中，蜂胶与酒精的重量比例为1:0.8-1.2，酒精浓度为70％-75％。
本发明的有益之处在于：
本发明利用老蜂巢制备的蜂蜡中含有的蜂巢素以及蜂胶、蜂蜜具有抗菌功能平衡鼻内菌群；利用天然蜂蜡及山茶油、薄荷油、维生素E的滋润保湿功能、将抗菌物质与鼻粘膜接触，以直达患部。而且组分均为天然物质，无毒副作用，无药味，且具备淡薄的香气，可长期使用，对鼻炎、感冒有很好的预防以及缓解效果。
具体实施方式
下面对本发明的具体实施方式作进一步说明。在此需要说明的是，对于这些实施方式的说明用于帮助理解本发明，但并不构成对本发明的限定。此外，下面所描述的本发明各个实施方式中所涉及的技术特征只要彼此之间未构成冲突就可以相互组合。
本发明主要以山茶油、蜂蜡、薄荷油、蜂蜜、蜂胶、维生素E等作为原料制作而成，推荐的配比范围如下(以重量份计)：山茶油45～55份、蜂蜡12～20份、薄荷油3～6份、蜂蜜12～20份、蜂胶8～14份、维生素E 0.1～0.3份。
实施例1：
原料配比：
山茶油45份、蜂蜡12份、薄荷油3份、蜂蜜12份、蜂胶8份、维生素E 0.1份。
制作方法如下：
(1)制备蜂蜡：采集天然老蜂巢，按照蜂蜡与水的重量比例为1:2-2.5加水熬制，大火烧至沸腾后，文火熬制30-40min，之后过滤去除杂质，制备纯净的蜂蜡；
(2)蜂胶溶液配制：将蜂胶放入适量酒精内，推荐蜂胶与酒精的重量比例为1:0.8-1.2，酒精浓度为70％-75％即可(酒精只是作为溶剂，后续将挥发，所以浓度太低会导致含水率太大，难以挥发，浓度太高的话则没有必要，增加成本)，反复搅动直至溶解得蜂胶溶液；
(3)将蜂胶溶液、山茶油、薄荷油、蜂蜜、维生素E按比例加入蜂蜡，并搅拌均匀；
(4)低温静置定型：将配制好的混合物自然降温成型。
实施例2：
原料配比：
具体的，所述组分的重量份比例为：山茶油55份、蜂蜡20份、薄荷油6份、蜂蜜20份、蜂胶14份、维生素E 0.3份。
制作方法与实施例一致。
实施例3：
原料配比：
山茶油50份、蜂蜡16份、薄荷油4份、蜂蜜16份、蜂胶11份、维生素E 0.2份。
制作方法与实施例一致。
本发明中：
蜜蜂巢脾即蜂巢，是蜜蜂栖息、繁育、生活的场所，巢脾除蜂蜡外还含有大量的生物活性成分如二十八烷醇、三十烷醇、油菜甾醇物、蜂蜡素等，其具有抗氧化、抑菌、抗炎镇痛和增强免疫等作用，可治疗鼻炎、肝炎等炎症。蜜蜂巢脾水提液和醇提液均对金黄色葡萄球菌、表皮葡萄球菌、铜绿假单胞菌、乙型溶血性链球菌、肺炎链球菌抑菌菌株均有一定的抑制效果。蜜蜂巢脾提取液都对DPPH自由基、OH-、O2-具有较好的清除作用；老巢脾提取物具有抑制透明质酸酶的活性，从而具备抗敏抗炎活性。巢脾水煮冷却后形成蜂蜡，具有抗氧化、抑菌、抗炎镇痛、增强免疫等作用。
蜂胶具有广谱抗菌、抗病毒、抗氧化等多种生物学活性，能清除体内的有害物质，增强机体免疫功能，还有助于治疗包括感冒、皮肤病、胃溃疡、烧伤、痔疮、牙龈炎、肿瘤及糖尿病等在内的多种疾病。
此外，蜂蜜具有抗菌消炎和锁水的作用，可润滑鼻腔黏膜，保持鼻腔黏膜湿润，减少干燥引起的鼻腔出血，缓解鼻腔疼痛；山茶油可增加鼻腔黏膜分泌，减轻鼻腔黏膜干燥，其中的儿茶酚胺具有抗炎作用具有一定的抗菌保湿效果；薄荷油的芳香具有通鼻窍的作用，可辅助缓解鼻子不通气；维生素E具有很好的保湿补水作用。
鼻腔在寒冷季节其温度接近35℃，蜂巢内的平均温度为35℃左右，蜂巢素、蜂胶等物质在此环境下具有良好的抗菌活性，结合山茶油、薄荷油、蜂蜜、维生素E等的抑菌消炎和锁水功效，达到修复鼻黏膜和润鼻作用，可以实现前期预防、中期治疗、后期修复的效果。
以上对本发明的实施方式作了详细说明，但本发明不限于所描述的实施方式。对于本领域的技术人员而言，在不脱离本发明原理和精神的情况下，对这些实施方式进行多种变化、修改、替换和变型，仍落入本发明的保护范围内。
Claims (8)
1.一种修复鼻粘膜的蜂巢润鼻膏，其特征在于，包括以下组分：山茶油、蜂蜡、薄荷油、蜂蜜、蜂胶、维生素E。
2.根据权利要求1所述的修复鼻粘膜的蜂巢润鼻膏，其特征在于，所述组分的重量份比例为：山茶油45～55份、蜂蜡12～20份、薄荷油3～6份、蜂蜜12～20份、蜂胶8～14份、维生素E 0.1～0.3份。
3.根据权利要求2所述的修复鼻粘膜的蜂巢润鼻膏，其特征在于，所述组分的重量份比例为：山茶油45份、蜂蜡12份、薄荷油3份、蜂蜜12份、蜂胶8份、维生素E 0.1份。
4.根据权利要求2所述的修复鼻粘膜的蜂巢润鼻膏，其特征在于，所述组分的重量份比例为：山茶油55份、蜂蜡20份、薄荷油6份、蜂蜜20份、蜂胶14份、维生素E 0.3份。
5.根据权利要求2所述的修复鼻粘膜的蜂巢润鼻膏，其特征在于，所述组分的重量份比例为：山茶油50份、蜂蜡16份、薄荷油4份、蜂蜜16份、蜂胶11份、维生素E 0.2份。
6.一种如要求1-5任一项所述的修复鼻粘膜的蜂巢润鼻膏的制作方法，其特征在于，包括以下步骤：
(1)制备蜂蜡：采集天然老蜂巢，加水熬制后过滤去除杂质，制备纯净的蜂蜡；
(2)蜂胶溶液配制：将蜂胶放入适量酒精内，反复搅动直至溶解得蜂胶溶液；
(3)将蜂胶溶液、山茶油、薄荷油、蜂蜜、维生素E按比例加入蜂蜡，并搅拌均匀；
(4)低温静置定型：将配制好的混合物自然降温成型。
7.根据权利要求6所述的修复鼻粘膜的蜂巢润鼻膏的制作方法，其特征在于：步骤1中，蜂蜡与水的重量比例为1:2-2.5，大火烧至沸腾后，文火熬制30-40min。
8.根据权利要求6所述的修复鼻粘膜的蜂巢润鼻膏的制作方法，其特征在于：步骤2中，蜂胶与酒精的重量比例为1:0.8-1.2，酒精浓度为70％-75％。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202210015718.2A CN114159353A (zh) | 2022-01-07 | 2022-01-07 | 修复鼻粘膜的蜂巢润鼻膏及其制备方法 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202210015718.2A CN114159353A (zh) | 2022-01-07 | 2022-01-07 | 修复鼻粘膜的蜂巢润鼻膏及其制备方法 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN114159353A true CN114159353A (zh) | 2022-03-11 |
Family
ID=80489107
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202210015718.2A Pending CN114159353A (zh) | 2022-01-07 | 2022-01-07 | 修复鼻粘膜的蜂巢润鼻膏及其制备方法 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN114159353A (zh) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN114886960A (zh) * | 2022-05-20 | 2022-08-12 | 庄五法 | 抗菌消炎皮肤修复膏 |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106963809A (zh) * | 2017-03-23 | 2017-07-21 | 邵诗琳 | 一种修复鼻粘膜的酵素润鼻膏及其制备方法 |
| CN107569536A (zh) * | 2017-09-22 | 2018-01-12 | 杨斌 | 一种鼻炎膏剂及其制备方法 |
| CN111821368A (zh) * | 2019-04-19 | 2020-10-27 | 鼻精灵(重庆)医疗科技有限公司 | 一种治疗鼻炎的组合物及含该组合物的鼻炎膏 |
| DE102019129085A1 (de) * | 2019-10-23 | 2021-04-29 | AXPHARM Sp. Z O.o. | Präparat zur Regeneration und Befeuchtung der Nasenschleimhaut |
-
2022
- 2022-01-07 CN CN202210015718.2A patent/CN114159353A/zh active Pending
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106963809A (zh) * | 2017-03-23 | 2017-07-21 | 邵诗琳 | 一种修复鼻粘膜的酵素润鼻膏及其制备方法 |
| CN107569536A (zh) * | 2017-09-22 | 2018-01-12 | 杨斌 | 一种鼻炎膏剂及其制备方法 |
| CN111821368A (zh) * | 2019-04-19 | 2020-10-27 | 鼻精灵(重庆)医疗科技有限公司 | 一种治疗鼻炎的组合物及含该组合物的鼻炎膏 |
| DE102019129085A1 (de) * | 2019-10-23 | 2021-04-29 | AXPHARM Sp. Z O.o. | Präparat zur Regeneration und Befeuchtung der Nasenschleimhaut |
Non-Patent Citations (1)
| Title |
|---|
| 余林生;刘在芳;琚大伟;程茂盛;刘苏燕;余海霞;: "蜜蜂巢脾的陈旧过程及其开发利用", 中国蜂业, no. 06, pages 39 - 40 * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN114886960A (zh) * | 2022-05-20 | 2022-08-12 | 庄五法 | 抗菌消炎皮肤修复膏 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US6197305B1 (en) | Anti-fungal compositions with prolonged activity | |
| US4382886A (en) | Method for extracting propolis and water soluble dry propolis powder | |
| WO2017101790A1 (zh) | 用于治疗皮肤瘙痒病症的药物组合物及其应用 | |
| CN114159353A (zh) | 修复鼻粘膜的蜂巢润鼻膏及其制备方法 | |
| KR100735541B1 (ko) | 비강세척제 조성물 및 그 제조방법 | |
| US20060088612A1 (en) | Composition for treatment of topical infection and methods of making and using same | |
| KR102170850B1 (ko) | 여드름 치료 또는 피부개선용 조성물 | |
| WO2019123483A1 (en) | A herbal antiseptic and wound healing preparation | |
| FR3070261A1 (fr) | Produit de combinaison pour soulager les symptomes lies aux infections des voies respiratoires superieures | |
| CN102846799A (zh) | 烧烫伤中药外用膏及其制备方法 | |
| CN112245498A (zh) | 一种中西药相结合的止痒药敷膏及其制备方法 | |
| CN111358851A (zh) | 一种用于治疗宠物皮肤病的凝胶剂及其制备方法 | |
| CN111821368A (zh) | 一种治疗鼻炎的组合物及含该组合物的鼻炎膏 | |
| JP6590233B1 (ja) | 皮膚疾患治療剤及びその製造方法 | |
| CN115337359B (zh) | 一种治疗螨虫皮炎的外用中药组合物及其制备方法 | |
| US20070184125A1 (en) | Use of extracts from gentiana lutea as an antimicrobial agent | |
| CN107714834A (zh) | 一种山茶油外用制剂的组合物、制备方法及其应用 | |
| CN108420905A (zh) | 一种防治口腔炎和咽炎油茶及其制备方法 | |
| CN110613804B (zh) | 一种用于犬猫外耳炎的中药组合物及其制备方法 | |
| KR102532005B1 (ko) | 반려 동물 피부 항염증용 조성물 | |
| CN108159294B (zh) | 用于改善牙龈健康的咀嚼片及其制备方法 | |
| CN102357145A (zh) | 一种治疗秃发的外用药软膏 | |
| US20200375881A1 (en) | Skin care product made from camellia sinensis and method of making the same | |
| CN104906379A (zh) | 一种治疗大疱性脓包疮的中药软膏及其制备方法 | |
| CN112741863A (zh) | 一种治疗皮肤创伤的药物及其制备方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20220311 |